Pig Kidneys for Humans: Trial Breakthrough

A pioneering clinical trial is now transplanting gene-edited pig kidneys into living human recipients, marking a significant advancement in xenotransplantation. Dr. Robert Montgomery, director of NYU Langone's Transplant Institute, revealed that the first transplant has occurred, with another planned for January, aiming to address the dire shortage of human organs. This approach utilizes pig organs edited in 10 places to minimize rejection.

The trial's expansion hinges on FDA approval, potentially involving 44 additional transplants. For participants, many of whom are ineligible for human transplants or have poor survival odds, this offers a crucial lifeline. Dr. Montgomery, who himself received a heart transplant, highlights the desperate need, stating, "there's just never going to be enough human organs."

Recent progress in gene-editing technology has made xenotransplantation viable, overcoming decades of skepticism. Montgomery previously conducted the world's first gene-edited pig-to-human organ transplant in a brain-dead individual in 2021. He envisions pig organs, with ongoing modifications, potentially becoming superior to human organs, offering a more sustainable solution for patients.